The DIAbetes MANagement and Treatment (DIAMANT) Cohort

References

• International Diabetes Federation. IDF Diabetes Atlas. Brussels: International Diabetes Federation; 2019.
   Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Nielen M, Poos R, Korevaar J. Diabetes Mellitus in Nederland Prevalentie En Incidentie: Heden, Verleden En Toekomst. Utrecht: Nivel; 2020.
   Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Mooy JM, Grootenhuis PA, de Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn study. Diabetes Care. 1995;18(9):1270–1273. doi:10.2337/diacare.18.9.1270
   PubMed Web of Science ®Google Scholar
• Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841.
   PubMed Web of Science ®Google Scholar
• Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–113. doi:10.1016/S2213-8587(14)70219-0
   PubMed Web of Science ®Google Scholar
• Overbeek JA. Type 2 diabetes, its pharmacological treatment and associations with cancer: (Pharmaco) epidemiological studies based on data from the PHARMO DIAMANT cohort: Amsterdam UMC – locatie VUmc, Vrije Universiteit. Amsterdam Public Health Research Institute; 2019.
   Google Scholar
• Stichting Informatievoorziening voor Zorg en Onderzoek (STIZON); 2022. Available from: https://stizon.nl/. Accessed April 7, 2022.
   Google Scholar
• Kuiper JG, Bakker M, Penning-van Beest FJA, Herings RMC. Existing data sources for clinical epidemiology: the PHARMO database network. Clin Epidemiol. 2020;12:415–422. doi:10.2147/CLEP.S247575
   PubMed Web of Science ®Google Scholar
• Struijs JN, de Jong-van Til JT, Lemmens LC, Drewes HW, de Bruin SR, Baan CA. Three years of bundled payment for diabetes care in the Netherlands. Bilthoven: national Institute for public health and the environment (RIVM) ministry of health, welfare and Sport; 2012.
   Google Scholar
• e-Diabetes Mellitus kernset (samenvatting) [e-Diabetes Mellitus core set]. Diabetesvereniging Nederland, ndf & Nederlands Huisartsen Genootschap; 2013. Available from: https://www.zorgstandaarddiabetes.nl/wp-content/uploads/2014/01/e-Diabetes-Mellitus-kernset-samenvatting-DEF.pdf. Accessed November 21, 2022.
   Google Scholar
• Bepalingenviewer: tabel Diagnostische Bepalingen versie [Examination viewer: table diagnostic examinations] 37 (14 juli 2021). Bepalingenclusters 16 (25 februari 2021); 2021. Available from: https://bepalingen.nhg.org/labcodes/determinations. Accessed April 7, 2022.
   Google Scholar
• Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, et al. Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1). J Eur Acad Dermatol Venereol. 2019;33(11):2143–2150. doi:10.1111/jdv.15601
   PubMed Web of Science ®Google Scholar
• Z-Index. Available from: https://www.z-index.nl/. Accessed April 7, 2022. Dutch.
   Google Scholar
• World Health Organization. Anatomical therapeutic chemical classification system; 2021. Available from: http://www.whocc.no/atc_ddd_index. Accessed April 7, 2022.
   Google Scholar
• International Classification of Primary Care; 2022. Available from: https://www.nhg.org/themas/artikelen/icpc. Accessed April 7, 2022. Dutch.
   Google Scholar
• Nederlands Huisartsen Genootschap (NHG). Adequate dossiervorming met het elektronisch patiëntdossier (ADEPD); 2019.
   Google Scholar
• Barents ESE, Bilo HJG, Bouma M, et al. NHG-Standaard Diabetes mellitus type 2; 2021.
   Google Scholar
• Overbeek JA, van der Heijden AW, Herings RM, Nijpels G. Meer dan verdubbeling van de prevalentie van diabetes - Diabetes mellitus in Nederland in de periode 1999-2014 [Prevalence of diabetes mellitus in the Netherlands more than doubled in the period 1999–2014]. Ned Tijdschr Geneeskd. 2017;160:D673. Dutch.
   Google Scholar
• Overbeek JA, Heintjes EM, Prieto-Alhambra D, et al. Type 2 diabetes mellitus treatment patterns across Europe: a population-based multi-database study. Clin Ther. 2017;39(4):759–770. doi:10.1016/j.clinthera.2017.02.008
   PubMed Web of Science ®Google Scholar
• Overbeek JA, Kuiper JG, van der Heijden A, et al. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes. Int J Colorectal Dis. 2019;34(2):269–276. doi:10.1007/s00384-018-3191-7
   PubMed Web of Science ®Google Scholar
• Overbeek JA, van Herk-Sukel MPP, Vissers PAJ, et al. Type 2 diabetes, but not insulin (Analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries. Diabetes Care. 2019;42(3):434–442. doi:10.2337/dc18-2146
   PubMed Web of Science ®Google Scholar
• Faber MJ, Burgers JS, Westert GP. A sustainable primary care system: lessons from the Netherlands. J Ambul Care Manage. 2012;35(3):174–181. doi:10.1097/JAC.0b013e31823e83a4
   PubMedGoogle Scholar
• van der Heijden AA, Rauh SP, Dekker JM, et al. The Hoorn Diabetes Care System (DCS) cohort. A prospective cohort of persons with type 2 diabetes treated in primary care in the Netherlands. BMJ Open. 2017;7(5):e015599.
   Google Scholar